Health Sciences Acquisitions Corporation 2 HSAQ
13.31 0.00 (+0.00%)
Jan 26, 2023, 3:59 PM EST
10.44 Day range 13.50
9.41 52-week range 13.80
- Market cap
- 149.23M
- EPS (ttm)
- -0.035
- Shares out
- 11.21M
- P/E ratio
- -532.40
- Volume
- 119.61K
- Avg volume
- 70.10K
- Open
- 10.80
- Previous close
- 13.31
- Day's range
- 10.44 – 13.50
- 52-week range
- 9.41 – 13.80
- Beta
- 0.08
No chart data for this range yet.
Key statistics
- Enterprise value
- 119.01M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -424.20K
- Total cash
- 175.16K
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 10.84%
- 50-day average
- 10.06
- 200-day average
- 9.96
Next earnings
Consensus EPS estimate 0.00.
About Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
News
Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Critical Comparison 
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Trading Up 1.3% – Here’s What Happened 
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Shares Down 2.9% – Should You Sell? 
Comparing Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) & INVO Fertility (NASDAQ:IVF) 
Stocks That Hit 52-Week Lows On Monday 
Earnings Scheduled For July 29, 2021 
Stocks That Hit 52-Week Highs On Wednesday 
Stocks That Hit 52-Week Highs On Monday - Stocks That Hit 52-Week Highs On Wednesday
Your note
Sign in to keep a note on HSAQ — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HSAC 2 HOLDINGS, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 5, 2020 | 4,360,960 |
| LEE ALICE | Officer and Treasurer | Purchase | Aug 3, 2020 | 10,000 |
| SIROTA STEPHANIE A | Officer | Purchase | Aug 3, 2020 | 0 |
| WONG RODERICK | Chief Executive Officer | Purchase | Jan 23, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 8.92% | 1,000,000 | 13.31M | Sep 29, 2022 |
| Blackrock Inc. | 7.05% | 790,436 | 10.52M | Sep 29, 2022 |
| Price (T.Rowe) Associates Inc | 6.46% | 724,565 | 9.64M | Sep 29, 2022 |
| RA Capital Management, L.P. | 5.44% | 610,283 | 8.12M | Sep 29, 2022 |
| Boxer Capital, LLC | 3.57% | 400,000 | 5.32M | Sep 29, 2022 |
| EcoR1 Capital, LLC | 3.57% | 400,000 | 5.32M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Health Sciences Fund | 5.36% | 600,927 | 8.00M | Sep 29, 2022 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 2.34% | 262,308 | 3.49M | Nov 29, 2022 |
| BlackRock Health Sciences Trust II | 2.08% | 233,344 | 3.11M | Sep 29, 2022 |
| Price (T.Rowe) Equity Series Inc.-Health Sciences Portf | 0.28% | 30,999 | 412.60K | Sep 29, 2022 |
| John Hancock Fds II-Health Sciences Fund | 0.17% | 19,166 | 255.10K | Aug 30, 2022 |
| John Hancock Var Ins Tr-Health Sciences Tr | 0.12% | 13,354 | 177.74K | Sep 29, 2022 |